1.Impact of pharmacogenetics on the drug therapy of epilepsy.
Li-li ZANG ; Li WANG ; Ye WU
Chinese Journal of Pediatrics 2011;49(8):599-602
2.Research advances in hereditary epilepsy and precision drug therapy.
Chinese Journal of Contemporary Pediatrics 2017;19(10):1118-1123
Epilepsy is a common nervous system disease. It has been found that the pathogenesis of epilepsy is associated mutations in various genes, including genes encoding voltage-dependent ion channel, genes encoding ligand-gated ion channel, and solute carrier family genes. Different types of epilepsy caused by different mutations have different responses to drugs, and therefore, diagnosis and medication guidance based on genes are new thoughts for developing therapies. With the application of next-generation sequencing technology, more and more genes will be determined, which helps to further study the pathogenic mechanism of mutant genes and provides a basis for precision drug therapy for epilepsy.
Epilepsy
;
drug therapy
;
etiology
;
genetics
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Ion Channels
;
genetics
;
Precision Medicine
4.Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan.
Yan WANG ; Li GAO ; Yan-Ping LIU ; Nan-Nan HUANG ; Shu-Jing XU ; Dong-Ju MA
Chinese Journal of Contemporary Pediatrics 2010;12(6):429-432
OBJECTIVETo investigate the distribution and frequency of UGTIA6 A541G genetic polymorphism in Han epileptic children from Henan and to evaluate the effect of UGTIA6 A541G genetic polymorphism on serum concentrations of valproic acid.
METHODSThe method of gas chromatography was used to assay serum concentrations of valproic acid. UGTIA6 A541G genetic polymorphism was screened by PCR-RFLP. Direct sequencing was used to confirm the expected sequences of each genotype.
RESULTSThe genotypic frequencies of UGTIA6 A541G were as follows: AA in 76 cases, AG in 65 cases and GG in 6 cases. The mean values of serum concentrations of valproic acid in patients with A541G AA, AG and GG were 3.91+/-1.57, 3.59+/-1.39 and 3.73+/-1.28 microg/mL, respectively (dose-adjusted trough concentration on a mg/kg basis). There were no significant differences in serum concentrations of valproic acid among the three groups.
CONCLUSIONSUGT1A6 A541G gene polymorphism does not influence serum concentrations of valproic acid in Han epileptic children. Individual differences in serum concentrations of valproic acid may be attributed to many factors.
Adolescent ; Anticonvulsants ; metabolism ; Child ; Child, Preschool ; China ; ethnology ; Epilepsy ; drug therapy ; genetics ; metabolism ; Glucuronosyltransferase ; genetics ; Humans ; Polymorphism, Genetic ; Valproic Acid ; metabolism
5.Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.
Ping WANG ; Qiuhong ZHOU ; Yanghao SHENG ; Beisha TANG ; Zhaoqian LIU ; Boting ZHOU
Journal of Central South University(Medical Sciences) 2014;39(5):433-441
OBJECTIVE:
To investigate whether single nucleotide polymorphisms (SNPs) of rs2298771 and rs3812718 of the sodium channel α-subunit type 1 (SCN1A) gene affect the efficacy of carbamazepine (CBZ) treatment for seizures in Chinese Han epileptic patients.
METHODS:
SNP rs2298771 and rs3812718 of the SCN1A gene from 628 patients were genotyped. CBZ monotherapy was administered to the subjects with new-onset partial seizures. The efficacy was defined as the decrease in the number of seizures. Four semi-quantitative levels were used to assess the efficacy: seizure-free (SF), >75% seizure decrease (SD), 50%-75% SD, and <50% SD in the number of seizures compared with patients' initial conditions.
RESULTS:
After the 12 month treatment with CBZ monotherapy, the rate of SF patients with G allele of the SNP rs2298771 was significantly lower than that in patients with the AA genotype (P=0.003). The heterozygote and homozygote of the G allele at SNP rs2298771 predicted the low SF rate (OR=2.101, 95% CI 1.289-3.425). Marginal significance was observed between the dichotomous efficacy of SF and non-SF in 3 partial seizure types (P=0.028).
CONCLUSION
rs2298771 is significantly associated with the efficacy of CBZ monotherapy in Chinese Han epileptic patients.
Alleles
;
Asian Continental Ancestry Group
;
Carbamazepine
;
therapeutic use
;
Epilepsy
;
Genotype
;
Humans
;
NAV1.1 Voltage-Gated Sodium Channel
;
genetics
;
Polymorphism, Single Nucleotide
;
Seizures
;
drug therapy
;
genetics
6.Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy.
Li CHEN ; Chang-Qin LIU ; Yan HU ; Zhi-Tian XIAO ; Yan CHEN ; Jian-Xiang LIAO
Chinese Journal of Contemporary Pediatrics 2007;9(1):11-14
OBJECTIVEP-glycoprotein 170 (P-gp) is a plausible biologic candidate for pharmacoresistance in epilepsy. The expression and efflux efficiency of P-gp is influenced by a polymorphism (C3435T) in the encoding gene (MDR1). The CC genotype at the MDR1 C3435T polymorphism was reported to be associated with the response to antiepileptic drug treatment. This study attempted to replicate this finding by examining the association of this genetic polymorphism with response to antiepileptic drug treatment in ethnic Han Chinese children with epilepsy.
METHODSTwo hundred and fourteen ethnic Han Chinese children with epilepsy were classified based on the response to antiepileptic drug treatment: drug-nonresponsive and drug-responsive. DNA samples were obtained from the patients. Genotypes of the C3435T polymorphism were determined by traditional polymerase chain reaction followed by restriction digestion (PCR-RFLP). The frequency of genotypes and alleles between the two groups was compared by Chi-square test.
RESULTSOf the 214 patients, 164 were drug-responsive and 50 were drug-nonresponsive. There were no significant differences in the allele frequency and genotype frequency between the two groups.
CONCLUSIONSThere is no an association between the CC genotype or C allele at the locus of C3435T in MDR1 gene and response to antiepileptic drug treatment in ethnic Han Chinese children with epilepsy.
ATP-Binding Cassette, Sub-Family B, Member 1 ; genetics ; Anticonvulsants ; therapeutic use ; Child ; China ; ethnology ; Epilepsy ; drug therapy ; genetics ; Gene Frequency ; Genotype ; Humans ; Polymorphism, Genetic ; Polymorphism, Single Nucleotide
7.Ring chromosome 20 syndrome.
Chinese Journal of Pediatrics 2013;51(9):710-712
Anticonvulsants
;
administration & dosage
;
therapeutic use
;
Brain
;
diagnostic imaging
;
physiopathology
;
Child
;
Child, Preschool
;
Chromosome Deletion
;
Chromosome Disorders
;
diagnosis
;
genetics
;
Chromosomes, Human, Pair 20
;
genetics
;
Electroencephalography
;
Epilepsy
;
diagnosis
;
drug therapy
;
genetics
;
Epilepsy, Complex Partial
;
diagnosis
;
drug therapy
;
genetics
;
Humans
;
Karyotyping
;
Radiography
;
Ring Chromosomes
8.Gene-to-Gene Interaction between Sodium Channel-Related Genes in Determining the Risk of Antiepileptic Drug Resistance.
Sin Young JANG ; Myeong Kyu KIM ; Kee Ra LEE ; Man Seok PARK ; Byeong Chae KIM ; Ki Hyun CHO ; Min Cheol LEE ; Yo Sik KIM
Journal of Korean Medical Science 2009;24(1):62-68
The pathogenesis of antiepileptic drug (AED) resistance is multifactorial. However, most candidate gene association studies typically assess the effects of candidate genes independently of each other, which is partly because of the limitations of the parametric-statistical methods for detecting the gene-to-gene interactions. A total of 200 patients with drug-resistant epilepsy and 200 patients with drug-responsive epilepsy were genotyped for 3 representative the single nucleotide polymorphisms (SNPs) of the voltage-gated sodium channel genes (SCN1A, SCN1B, and SCN2A) by polymerase chain reaction and direct sequencing analysis. Besides the typical parametric statistical method, a new statistical method (multifactor dimensionality reduction [MDR]) was used to determine whether gene-to-gene interactions increase the risk of AED resistance. None of the individual genotypes or alleles tested in the present study showed a significant association with AED resistance, regardless of their theoretical functional value. With the MDR method, of three possible 2-locus genotype combinations, the combination of SCN2A-PM with SCN1B-PM was the best model for predicting susceptibility to AED resistance, with a p value of 0.0547. MDR, as an analysis paradigm for investigating multi-locus effects in complex disorders, may be a useful statistical method for determining the role of gene-to-gene interactions in the pathogenesis of AED resistance.
Adolescent
;
Adult
;
Alleles
;
Anticonvulsants/*therapeutic use
;
Case-Control Studies
;
Child
;
Child, Preschool
;
Data Interpretation, Statistical
;
Drug Resistance
;
Epilepsy/drug therapy/*genetics
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Humans
;
Infant
;
Male
;
Polymorphism, Single Nucleotide
;
Sodium Channels/*genetics
9.Advances in clinical and molecular genetic research on pyridoxine dependent epilepsy.
Chinese Journal of Pediatrics 2013;51(11):867-870
2-Aminoadipic Acid
;
analogs & derivatives
;
analysis
;
Aldehyde Dehydrogenase
;
genetics
;
Anticonvulsants
;
therapeutic use
;
Biomarkers
;
analysis
;
Brain
;
pathology
;
DNA Mutational Analysis
;
Electroencephalography
;
Epilepsy
;
diagnosis
;
drug therapy
;
genetics
;
Genetic Association Studies
;
Humans
;
Infant
;
Infant, Newborn
;
Magnetic Resonance Imaging
;
Mutation, Missense
;
Prognosis
;
Pyridoxine
;
therapeutic use
;
Seizures
;
diagnosis
;
drug therapy
;
genetics
;
Status Epilepticus
;
diagnosis
;
drug therapy
;
genetics
10.Screening for glutamate-induced and dexamethasone-downregulated epilepsy-related genes in rats by mRNA differential display.
Chun-ling MA ; Chang-geng ZHU ; Ming FAN ; Shu-hong LIU ; Qing-ying LIU ; Bin CONG
Chinese Medical Journal 2006;119(6):488-495
BACKGROUNDIt is known that excessive release of glutamate can induce excitotoxicity in neurons and lead to seizure. Dexamethasone has anti-seizure function. The aim of this study was to investigate glutamate-dexamethasone interaction in the pathogenesis of epilepsy, identify differentially expressed genes in the hippocampus of glutamate-induced epileptic rats by mRNA differential display, and observe the effects of dexamethasone on these genes expression.
METHODSSeizure models were established by injecting 5 microl (250 microg/microl) monosodium glutamate (MSG) into the lateral cerebral ventricle in rats. Dexamethasone (5 mg/kg) was injected intraperitoneally at 30 minutes after MSG inducing convulsion. The rats' behavior and electroencephalogram (EEG) were then recorded for 1 hour. The effects of dexamethasone on gene expression were observed in MSG-induced epileptic rats at 1 hour and 6 hours after the onset of seizure by mRNA differential display. The differentially expressed genes were confirmed by Dot blot.
RESULTSEEG and behaviors showed that MSG did induce seizure, and dexamethasone could clearly alleviate the symptom. mRNA differential display showed that MSG increased the expression of some genes in epileptic rats and dexamethasone could downregulate their expression. From more than 10 differentially expressed cDNA fragments, we identified a 226 bp cDNA fragment that was expressed higher in the hippocampus of epileptic rats than that in the control group. Its expression was reduced after the administration of dexamethasone. Sequence analysis and protein alignment showed that the predicted amino acid sequence of this cDNA fragment kept 43% identity to agmatinase, a member of the ureohydrolase superfamily.
CONCLUSIONSThe results of the current study suggest that the product of the 226 bp cDNA has a function similar to agmatinase. Dexamethasone might relax alleviate seizure by inhibiting expression of the gene.
Animals ; Base Sequence ; Dexamethasone ; pharmacology ; Electroencephalography ; drug effects ; Epilepsy ; chemically induced ; drug therapy ; genetics ; Gene Expression Profiling ; Gene Expression Regulation ; drug effects ; Male ; Molecular Sequence Data ; Oligonucleotide Array Sequence Analysis ; Rats ; Rats, Sprague-Dawley ; Sodium Glutamate ; pharmacology